XML 50 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Cash Flows From Operating Activities:    
Net loss $ (8,325,488) $ (3,336,435)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 46,945 21,875
Warranty provision 13,495 0
Inventory write-off (193,506) 0
Non-cash lease expense 80,069 0
Share-based compensation 1,536,096 512,988
Common shares issued for services 102,600 0
Changes in assets and liabilities:    
Accounts receivable (190,951) (4,396)
Inventories (1,892,768) (27,075)
Prepaid expenses and other current assets (136,084) (63,982)
Accounts payable 174,052 196,750
Operating lease liability (62,851) 0
Customer deposits 343,724 0
Accrued liabilities and other 112,346 8,139
Deferred compensation (96,000) 0
Deferred revenue 2,684 0
Net cash used in operating activities (8,485,637) (2,692,136)
Cash Flows From Investing Activities:    
Capital expenditures for property and equipment (256,742) (14,225)
Investment in patents and trademarks (114,274) (120,070)
Long-term deposits (11,169) 0
Net cash used in investing activities (382,185) (134,295)
Cash Flows From Financing Activities:    
Sale of common stock and warrants 12,499,994 13,683,222
Offering costs paid on sale of stock and warrants (1,148,780) (1,542,436)
Proceeds from exercise of warrants 2,112,117 0
Offering costs paid on exercise of warrants (28,666) 0
Proceeds from exercise of stock options 58,125 0
Payment of notes payable 0 (39,435)
Net cash provided by financing activities 13,492,790 12,101,351
Net increase in cash and cash equivalents 4,624,968 9,274,920
Cash and cash equivalents, beginning of period 12,358,896 3,083,976
Cash and cash equivalents, end of period 16,983,864 12,358,896
Supplemental Disclosure of Non-Cash Investing and Financing Activities:    
Interest paid 0 1,304
Prepaid insurance financed with note payable 0 39,435
Right-of-use assets and liabilites recorded during period 341,000 0
Issuance costs relating to warrants issued to public offering selling agent $ 205,894 $ 664,427